《世界卫生组织乳腺肿瘤分类（第4版）概述》，重点关注第3版以来的问题及更新内容。
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.
作者信息
Sinn Hans-Peter, Kreipe Hans
机构信息
Sektion für Gynäkologische Pathologie, Pathologisches Institut, Ruprecht-Karls-Universität Heidelberg, Germany.
Institut für Pathologie, Medizinische Hochschule Hannover, Germany.
出版信息
Breast Care (Basel). 2013 May;8(2):149-54. doi: 10.1159/000350774.
Abstract
The WHO Classification of Tumors of the Breast, 4th edition, is an update to the 3rd edition that was published in 2003, and covers all neoplastic and preneoplastic lesions of the breast. Changes to the 4th edition include new aspects and changes to the terminology that reflect our present-day knowledge of these lesions. Definitions for histopathological diagnosis are complemented by a description of clinical features, epidemiology, macroscopy, genetics, and prognostic and predictive features. In this review of the WHO classification, we have focused on invasive carcinomas, precursor lesions, and some benign epithelial proliferations.
摘要
《世界卫生组织乳腺肿瘤分类》第4版是2003年出版的第3版的更新版本，涵盖了乳腺的所有肿瘤性和肿瘤前病变。第4版的变化包括反映我们目前对这些病变认识的新内容和术语变化。组织病理学诊断的定义辅以临床特征、流行病学、大体检查、遗传学以及预后和预测特征的描述。在本次对世界卫生组织分类的综述中，我们重点关注浸润性癌、前驱病变和一些良性上皮增生。
相似文献
1
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.《世界卫生组织乳腺肿瘤分类（第4版）概述》，重点关注第3版以来的问题及更新内容。
Breast Care (Basel). 2013 May;8(2):149-54. doi: 10.1159/000350774.
2
Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012.肌上皮和上皮-肌上皮、间叶和纤维上皮性乳腺病变：WHO 2012 年乳腺肿瘤分类的更新。
J Clin Pathol. 2013 Jun;66(6):465-70. doi: 10.1136/jclinpath-2012-201078. Epub 2013 Mar 26.
3
Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.外科神经病理学进展：对世界卫生组织中枢神经系统肿瘤分类第4版引入变化的综述
Arch Pathol Lab Med. 2008 Jun;132(6):993-1007. doi: 10.5858/2008-132-993-SNUARO.
5
Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".妇科生殖道肿瘤分类的最新进展：世界卫生组织“蓝皮书”第五版更新。
Arch Pathol Lab Med. 2023 Oct 1;147(10):1204-1216. doi: 10.5858/arpa.2022-0166-RA.
6
Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".消化系统肿瘤最新进展：世界卫生组织第五版《蓝皮书》更新内容。
Arch Pathol Lab Med. 2021 May 1;145(5):607-626. doi: 10.5858/arpa.2020-0047-RA.
7
[Invasive breast cancer: the current WHO classification].[浸润性乳腺癌：世界卫生组织现行分类]
Pathologe. 2014 Feb;35(1):7-17. doi: 10.1007/s00292-013-1841-7.
8
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.世界卫生组织头颈部肿瘤分类第4版更新：牙源性和颌面骨肿瘤
Head Neck Pathol. 2017 Mar;11(1):68-77. doi: 10.1007/s12105-017-0794-1. Epub 2017 Feb 28.
9
Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis.日本原发性肝癌新分类（第4版）对肝细胞癌患者的预后评估性能：一项验证分析。
Hepatol Res. 2002 Dec;24(4):395-403. doi: 10.1016/s1386-6346(02)00144-4.
10
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.世界卫生组织头颈部肿瘤分类第4版更新内容：2017年世界卫生组织下咽、喉、气管及咽旁间隙肿瘤蓝皮书有哪些新内容。
Head Neck Pathol. 2017 Mar;11(1):23-32. doi: 10.1007/s12105-017-0788-z. Epub 2017 Feb 28.
引用本文的文献
1
Genomic Predictive Biomarkers in Breast Cancer: The and .乳腺癌中的基因组预测生物标志物：以及。 （你提供的原文似乎不完整，翻译可能不太准确，你可补充完整原文后再让我翻译）
Int J Mol Sci. 2025 Jul 28;26(15):7300. doi: 10.3390/ijms26157300.
2
The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer.体重指数与乳腺癌患者新辅助化疗反应之间的关联。
Breast Cancer Res. 2025 Jul 11;27(1):130. doi: 10.1186/s13058-025-02083-w.
3
Real-World, National Study of Palbociclib in HR+/HER2- Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021.哌柏西利治疗激素受体阳性/人表皮生长因子受体2阴性转移性乳腺癌的真实世界全国性研究：2.5年随访PALBO01/2021
Diagnostics (Basel). 2025 May 5;15(9):1173. doi: 10.3390/diagnostics15091173.
4
HbA levels and breast cancer prognosis in women without diabetes.非糖尿病女性的糖化血红蛋白（HbA）水平与乳腺癌预后
BMC Cancer. 2025 Apr 28;25(1):790. doi: 10.1186/s12885-025-14121-z.
5
Artificial Intelligence in Histologic Diagnosis of Ductal Carcinoma In Situ.人工智能在导管原位癌组织学诊断中的应用
Mayo Clin Proc Digit Health. 2023 Jun 25;1(3):267-275. doi: 10.1016/j.mcpdig.2023.05.008. eCollection 2023 Sep.
6
Breast cancer treatment modalities, treatment delays, and survival in Brunei Darussalam.文莱达鲁萨兰国的乳腺癌治疗方式、治疗延误及生存率
BMC Cancer. 2025 Mar 20;25(1):510. doi: 10.1186/s12885-025-13861-2.
7
PRR13 expression as a prognostic biomarker in breast cancer: correlations with immune infiltration and clinical outcomes.PRR13表达作为乳腺癌的预后生物标志物：与免疫浸润和临床结局的相关性
Front Mol Biosci. 2025 Mar 3;12:1518031. doi: 10.3389/fmolb.2025.1518031. eCollection 2025.
8
Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer.化生性乳腺癌患者的致病性种系变异
JAMA Netw Open. 2025 Feb 3;8(2):e2460312. doi: 10.1001/jamanetworkopen.2024.60312.
9
Mastectomy, HER2 Receptor Positivity, NPI, Late Stage and Luminal B-Type Tumor as Poor Prognostic Factors in Geriatric Patients with Breast Cancer.乳房切除术、HER2受体阳性、诺丁汉预后指数、晚期和管腔B型肿瘤作为老年乳腺癌患者的不良预后因素
Diagnostics (Basel). 2024 Dec 25;15(1):13. doi: 10.3390/diagnostics15010013.
10
Secretory Breast Carcinoma: A Rare Breast Cancer With an Excellent Behavior.分泌性乳腺癌：一种行为良好的罕见乳腺癌。
Cureus. 2024 Nov 9;16(11):e73312. doi: 10.7759/cureus.73312. eCollection 2024 Nov.
本文引用的文献
1
Metaplastic breast cancer: clinicopathological features and its prognosis.化生性乳腺癌：临床病理特征及其预后。
J Clin Pathol. 2012 May;65(5):441-6. doi: 10.1136/jclinpath-2011-200586. Epub 2012 Mar 12.
2
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.腺样囊性癌构成三阴性和基底样乳腺癌中基因组上不同的亚群。
J Pathol. 2012 Jan;226(1):84-96. doi: 10.1002/path.2974. Epub 2011 Oct 20.
3
A clinically relevant gene signature in triple negative and basal-like breast cancer.三阴性和基底样乳腺癌中具有临床相关性的基因特征。
Breast Cancer Res. 2011 Oct 6;13(5):R97. doi: 10.1186/bcr3035.
4
Concordance in histological and biological parameters between first and second primary breast cancers.首次和二次原发性乳腺癌的组织学和生物学参数的一致性。
Cancer. 2011 Mar 1;117(5):907-15. doi: 10.1002/cncr.25587. Epub 2010 Oct 13.
5
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.乳腺黏液癌在基因组上有别于非特殊型浸润性导管癌。
J Pathol. 2010 Nov;222(3):282-98. doi: 10.1002/path.2763.
6
Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma.乳腺浸润性神经内分泌癌：一种侵袭性乳腺癌的独特亚型。
Cancer. 2010 Oct 1;116(19):4463-73. doi: 10.1002/cncr.25352.
7
Breast core needle biopsy: issues and controversies.乳腺芯针活检：问题与争议。
Mod Pathol. 2010 May;23 Suppl 2:S36-45. doi: 10.1038/modpathol.2010.34.
8
Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.乳腺涎腺型肿瘤：一类包括低恶性潜能的“三阴性癌”在内的良性和恶性肿瘤谱。
Semin Diagn Pathol. 2010 Feb;27(1):77-90. doi: 10.1053/j.semdp.2009.12.007.
9
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.乳腺癌中的雄激素受体：在雌激素受体阳性肿瘤和具有大汗腺分化的雌激素受体阴性肿瘤中的表达。
Mod Pathol. 2010 Feb;23(2):205-12. doi: 10.1038/modpathol.2009.159. Epub 2009 Nov 6.
10
The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.炎症和髓样组织学类型在乳腺浸润性癌中的预后意义。
Eur J Cancer. 2009 Jul;45(10):1780-7. doi: 10.1016/j.ejca.2009.02.014. Epub 2009 Mar 14.
Zotero 插件